Postoperative radiation therapy for carcinoma of the uterine cervix

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 24, Issue 2, 2006, Pages 91-97

  Uno, Takashi ^a   Isobe, Koichi ^a   Yamamoto, Seiji ^a   Kawata, Tetsuya ^a   Ito, Hisao ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adjuvant; Cervical cancer; Postoperative radiation therapy; Risk factor

Indexed keywords

CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; HIGH RISK POPULATION; HUMAN; JAPAN; METASTASIS; RADICAL HYSTERECTOMY; REVIEW; UTERINE CERVIX CARCINOMA;

COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYSTERECTOMY; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 33645777773     PISSN: 02882043     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02493274     Document Type: Review

References (40)

1. Hoskins WJ, Ford JH Jr, Lutz MH, Averette HE. Radical hysterectomy and pelvic lymphadenectomy for the management of early invasive cancer of the cervix. Gynecol Oncol, 4: 278-290, 1976.
2. Pettersson F. Annual report on the results of treatment in gynecologic cancer (FIGO). Int J Gynecol Obstet, 36S: 27-127, 1991.
3. Koh WJ, Panwala K, Greer B. Adjuvant therapy for high-risk, early stage cervical cancer. Semin Radiat Oncol, 10: 51-60, 2000.
4. Chatani M, Nose T, Masaki N, Inoue T. Adjuvant radiotherapy after radical hysterectomy of the cervical cancer. Prognostic factors and complications. Strahlenther Onkol, 174: 504-509, 1998.
5. Uno T, Ito H, Itami J, et al. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors. Anticancer Res, 20: 2235-2239, 2000.
6. Aoki Y, Sasaki M, Watanabe M, et al. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol Oncol, 77: 305-309, 2000.
7. Kodaira T, Fuwa N, Nakanishi T, et al. Retrospective analysis of postoperative radiotherapy for node-negative cervical carcinoma with stage IB-IIB disease. Jpn J Clin Oncol, 32: 255-261, 2002.
8. Shinohara S, Ochi T, Miyazaki T, et al. Histopathological prognostic factors in patients with cervical cancer treated with radical hysterectomy and postoperative radiotherapy. Int J Clin Oncol, 9: 503-509, 2004.
9. Fuller AF Jr, Elliott N, Kosloff C, Hoskins WJ, Lewis JL Jr. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol, 33: 34-39, 1989.
10. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol, 38: 352-357, 1990.
11. Sevin BU, Lu Y, Bloch DA, Nadji M, Koechli OR, Averette HE. Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis. Cancer, 78: 1438-1446, 1996.
12. Piver MS, Chung WS. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol, 46: 507-510, 1975.
13. Van Nagel Jr, Donaldson ES, Parker JC, Van Dyke AH, Wood EG. The prognostic significance of cell type and lesion size in patients with cervical cancer treated by radical surgery. Gynecol Oncol, 5: 142-151, 1977.
14. Burghardt E, Pickel H. Local spread and lymph node involvement in cervical cancer. Obstet Gynecol, 52: 138-145, 1978.
15. Inoue T, Casanova HA, Morita K, Chihara T. The prognostic significance of the minimum thickness of uninvolved cervix in patients with cervical carcinoma stages IB, IIA, and IIB. Gynecol Oncol, 24: 220-229, 1986.
16. Delgado G, Bundy BN, Fowler WC Jr, et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol, 35: 314-320, 1989.
17. Thomas GT, Dembo AJ. Is there a role for adjuvant pelvic radiotherapy after radical hysterectomy in early stage cervical cancer? Int J Gynecol Cancer, 1: 1-8, 1991.
18. Eifel PJ, Levenback C, Wharton JT, Oswald MJ. Time course and incidence of late complications in patients treated with radiation therapy for FIGO IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys, 32: 1289-1300, 1995.
19. Toita T, Kakinohana Y, Shinzato S, et al. Tumor diameter/volume and pelvic node status assessed by magnetic resonance imaging (MRI) for uterine cervical cancer treated with irradiation. Int J Radiat Oncol Biol Phys, 43: 777-782, 1999.
20. Chung CK, Nahhas WA, Stryker JA, Curry SL, Abt AB, Mortel R. Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix. Am J Obstet Gynecol, 138: 550-556, 1980.
21. Hsu CT, Cheng YS, Su SC. Prognosis of uterine cervical cancer with extensive lymph node metastases. Special emphasis on the value of pelvic lymphadenectomy in the surgical treatment of uterine cervical cancer. Am J Obstet Gynecol, 114: 954-962, 1972.
22. van Bommel PF, van Lindert AC, Kock HC, Leers WH, Neijt JP. A review of prognostic factors in early-stage carcinoma of the cervix (FIGO IB and IIA) and implications for treatment strategy. Eur J Obstet Gynecol Reprod Biol, 26: 69-84, 1987.
23. Benedet JL, Odicino F, Maisonneuve P, et al. Carcinoma of the cervix uteri. Int J Gynaecol Obstet, 83 (Suppl 1): 41-78, 2003.
24. Kim JH, Kim HJ, Hong S, Wu HG, Ha SW. Post-hysterectomy radiotherapy in FIGO stage IB-IIB uterine cervical carcinoma. Gynecol Oncol, 96: 407-414, 2005.
25. Artman LE, Hoskins WJ, Bibro MC, et al. Radical hysterectomy and pelvic lymphadenectomy for stage IB carcinoma of the cervix: 21 years experience. Gynecol Oncol, 28: 8-13, 1987.
26. Alvarez RD, Soong SJ, Kinney WK, et al. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol, 35: 130-135, 1989.
27. Lee YN, Wang KL, Lin MH, et al. Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: a clinical review of 954 cases. Gynecol Oncol, 32: 135-142, 1989.
28. Smiley LM, Burke TW, Silva EG, Morris M, Gershenson DM, Wharton JT. Prognostic factors in stage IB squamous cervical cancer patients with low risk for recurrence. Obstet Gynecol, 77: 271-275, 1991.
29. Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol, 73: 177-183, 1999.
30. Gonzalez D, Ketting BW, van Bunningen B, van Dijk JD. Carcinoma of the uterine cervix stage IB and IIA: results of postoperative irradiation in patients with microscopic infiltration in the parametrium and/or lymph node metastasis. Int J Radiat Oncol Biol Phys, 16: 389-395, 1989.
31. Frigerio L, Busci L, Rabaiotti E, Mariani A. Adjunctive radiotherapy after radical hysterectomy in high risk early stage cervical carcinoma. Assessment of morbidity and recurrences. Eur J Gynaecol Oncol, 15: 132-137, 1994.
32. Garipagaoglu M, Tulunay G, Kose MF, Yalvac S, Kayikcioglu F, Cakmak A. Prognostic factors in stage IB-IIA cervical carcinomas treated with postoperative radiotherapy. Eur J Gynaecol Oncol, 20: 131-135, 1999.
33. Yeh SA, Wan Leung S, Wang CJ, Chen HC. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors. Gynecol Oncol, 72: 10-15, 1999.
34. Tsai CS, Lai CH, Wang CC, et al. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Gynecol Oncol, 75: 328-333, 1999.
35. Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol, 18: 1606-1613, 2000.
36. Uno T, Ito H, Isobe K, et al. Postoperative pelvic radiotherapy for cervical cancer patients with positive parametrial invasion. Gynecol Oncol, 96: 335-340, 2005.
37. Monk BJ, Wang J, Im S, et al. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol, 96: 721-728, 2005.
38. Yamazaki A, Shirato H, Nishioka T, et al. Reduction of late complications after irregularly shaped four-field whole pelvic radiotherapy using computed tomographic simulation compared with parallel-opposed whole pelvic radiotherapy. Jpn J Clin Oncol, 30: 180-184, 2000.
39. Kim RY, McGinnis LS, Spencer SA, Meredith RF, Jennelle RL, Salter MM. Conventional four-field pelvic radiotherapy technique without computed tomography-treatment planning in cancer of the cervix: potential geographic miss and its impact on pelvic control. Int J Radiat Oncol Biol Phys, 31: 109-112, 1995.
40. Zunino S, Rosato O, Lucino S, Jauregui E, Rossi L, Venencia D. Anatomic study of the pelvis in carcinoma of the uterine cervix as related to the box technique. Int J Radiat Oncol Biol Phys, 44: 53-59, 1999.